Cargando...
NYSE: BAX
Métricas de valuación y rentabilidad de la empresa frente a sus pares de industria. La empresa analizada aparece destacada en la primera fila.
| Empresa | Market Cap | P/E | EV/EBITDA | P/S | ROE | Margen Op. |
|---|---|---|---|---|---|---|
BAX Baxter International Inc.Esta empresa | $10,8B | N/A | 8,74x | 0,81x | -15,01% | 6,03% |
ISRG Intuitive Surgical, Inc. | $145,6B | N/A | 40,20x | 15,08x | 17,23% | 30,87% |
BDX Becton, Dickinson and Company | $40,3B | N/A | 9,18x | 1,90x | 6,67% | 13,28% |
RMD ResMed Inc. | $28,3B | N/A | 13,77x | 5,41x | 25,25% | 35,33% |
WST West Pharmaceutical Services, I | $23,2B | N/A | 25,92x | 7,17x | 19,13% | 21,70% |
SOLV Solventum Corporation | $13,7B | N/A | 15,25x | 1,53x | 34,79% | 5,58% |